An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in Pulmonary Hypertension (ASCENT Study) LTI-401

Investigator: Sandeep Sahay, MD

Study Coordinator: Jennifer Lee

Status: Enrolling

ClinicalTrials.gov Number: N/A

Phone: 713.363.7537

Protocol Number: PRO00037805

Description

Study LTI-401 is an open-label, multicenter study which will evaluate the safety and tolerability ofLIQ861 in subjects who have WHO Group 1 & 3 PH. Cohort A will include approximately 60 subjects who have WHO Group 3 Pulmonary Hypertension associated with interstitial lung disease (PH-ILD). Additional cohorts from wither Group 1 or Group 3 may be defined in the future protocol amendments. Scheduled study visits to the clinic will occur at Screening, Baseline, Week 8, 16, 24 and 52.
More to Explore